Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bousseau

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Agents and Actions|May 1, 1992
RP 54745, a potential antirheumatic compound. I. Inhibitor of macrophage stimulation and interleukin-1 productionF Folliard, A Bousseau, B Terlain
Agents and Actions|May 1, 1992
RP 54745, a potential antirheumatic compound. II. In vivo properties in different animal modelsF Folliard, A Bousseau, B Terlain
Experimental Brain Research|January 1, 1991
Modulation of interleukin-1 and tumor necrosis factor expression by beta-adrenergic agonists in mouse ameboid microglial cellsE Hetier, J Ayala, A Bousseau, et al.
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1989
[Plasma concentration of tumor necrosis factor correlated with gravity of septic shock]M Romieu, A Bousseau, F Riche, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1993
A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cellsD Weissman, G Poli, A Bousseau, et al.
The Journal of Clinical Investigation|May 1, 1991
Acute effects of tumor necrosis factor on the microcirculation in rat cremaster muscleE Vicaut, X Hou, D Payen, et al.
Journal of the Neurological Sciences|November 1, 1994
Prevention of HIV coat protein (gp120) toxicity in cortical cell cultures by riluzoleP Sindou, P Couratier, F Esclaire, et al.
Research in Virology|May 1, 1994
Treatment of human monocyte-derived macrophages with a TNF alpha synthesis inhibitor prior to HIV1 infection: consequences on cytokine production and viral replicationR Le Naour, H Raoul, A Mabondzo, et al.
Journal of Lipid Mediators|November 1, 1989
RP 55778, a PAF receptor antagonist, prevents and reverses LPS-induced hemoconcentration and TNF releaseA Floch, A Bousseau, E Hetier, et al.
Journal of Neuroscience Research|October 1, 1988
Brain macrophages synthesize interleukin-1 and interleukin-1 mRNAs in vitroE Hetier, J Ayala, P Denèfle, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Agents and Actions|May 1, 1992
RP 54745, a potential antirheumatic compound. I. Inhibitor of macrophage stimulation and interleukin-1 productionF Folliard, A Bousseau, B Terlain
Agents and Actions|May 1, 1992
RP 54745, a potential antirheumatic compound. II. In vivo properties in different animal modelsF Folliard, A Bousseau, B Terlain
Experimental Brain Research|January 1, 1991
Modulation of interleukin-1 and tumor necrosis factor expression by beta-adrenergic agonists in mouse ameboid microglial cellsE Hetier, J Ayala, A Bousseau, et al.
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1989
[Plasma concentration of tumor necrosis factor correlated with gravity of septic shock]M Romieu, A Bousseau, F Riche, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 1993
A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cellsD Weissman, G Poli, A Bousseau, et al.
The Journal of Clinical Investigation|May 1, 1991
Acute effects of tumor necrosis factor on the microcirculation in rat cremaster muscleE Vicaut, X Hou, D Payen, et al.
Journal of the Neurological Sciences|November 1, 1994
Prevention of HIV coat protein (gp120) toxicity in cortical cell cultures by riluzoleP Sindou, P Couratier, F Esclaire, et al.
Research in Virology|May 1, 1994
Treatment of human monocyte-derived macrophages with a TNF alpha synthesis inhibitor prior to HIV1 infection: consequences on cytokine production and viral replicationR Le Naour, H Raoul, A Mabondzo, et al.
Journal of Lipid Mediators|November 1, 1989
RP 55778, a PAF receptor antagonist, prevents and reverses LPS-induced hemoconcentration and TNF releaseA Floch, A Bousseau, E Hetier, et al.
Journal of Neuroscience Research|October 1, 1988
Brain macrophages synthesize interleukin-1 and interleukin-1 mRNAs in vitroE Hetier, J Ayala, P Denèfle, et al.
Pageof 3